<DOC>
	<DOCNO>NCT01978444</DOCNO>
	<brief_summary>Radical gastrectomy gastric cancer D2 lymph node dissection widely apply advanced gastric cancer . However , patient , tumor local-regional recurrence proven unavoidable . Recently , many clinical study prove cancer cell cancer node exist mesogastrium hardly remove conventional radical gastrectomy D2 lymphadenectomy . It suggest Complete mesogastrium excision ( CME ) imperative add D2 lymphadenectomy order reduce risk local recurrence . Thus , comparison short-term long-term outcome laparoscopic D2 lymphadenectomy plus complete mesogastrium excision conventional laparoscopic D2 lymphadenectomy locally advanced gastric cancer base well design randomize control trial need .</brief_summary>
	<brief_title>Study Laparoscopic D2 Lymphadenectomy Plus Complete Mesogastrium Excision（D2+CME）for Advanced Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Age 18 75 year Primary gastric adenocarcinoma ( papillary , tubular , mucinous , signet ring cell , poorly differentiate ) confirm pathologically endoscopic biopsy cT24a , N03 , M0 preoperative evaluation accord AJCC Cancer Staging Manual Seventh Edition Expected curative resection gastrectomy D2 lymphadenectomy Performance status 0 1 ECOG ( Eastern Cooperative Oncology Group ) scale ASA ( American Society Anesthesiology ) score class I , II , III Informed consent obtain patient appoint agent Patients treat neoadjuvant chemotherapy radiation therapy ; Patients history upper abdominal surgery ; History severe comorbidities tolerate laparoscopic surgery , severe heart lung disease , heart function clinical stage 2 , pulmonary infection , moderate severe COPD , chronic bronchitis , severe diabetes / renal insufficiency , severe hepatitis / function rank CHILD B grade , severe malnutrition , etc ; Patients suffer malignant disease study gastric malignant disease , lymphoma stromal tumor , etc . ; Pregnant woman woman lactation ; Patients mental sickness ; The patient compliance bad researcher expect good patient compliance ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>D2 lymphadenectomy</keyword>
	<keyword>Complete Mesogastrium Excision</keyword>
</DOC>